Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.

[1]  G. Dangas,et al.  Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. , 2015, International journal of cardiology.

[2]  Jun-Jie Zhang,et al.  Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug‐eluting stent , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  J. Spertus,et al.  Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). , 2015, JACC. Cardiovascular interventions.

[4]  G. Werner,et al.  Periprocedural ischaemia during recanalisation of chronic total coronary occlusions: the influence of the transcollateral retrograde approach. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  C. Di Mario,et al.  Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. , 2014, Journal of the American College of Cardiology.

[6]  Subhash Banerjee,et al.  Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study. , 2014, JACC. Cardiovascular interventions.

[7]  Seung‐Jung Park,et al.  Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. , 2013, European heart journal.

[8]  Subhash Banerjee,et al.  Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. , 2013, JACC. Cardiovascular interventions.

[9]  M. Pencina,et al.  Troponin criteria for myocardial infarction after percutaneous coronary intervention. , 2012, Archives of internal medicine.

[10]  M. Hayashi,et al.  Impact of chronic kidney disease on the incidence of peri-procedural myocardial injury in patients undergoing elective stent implantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Y. Song,et al.  Periprocedural Myocardial Infarction After Retrograde Approach for Chronic Total Occlusion of Coronary Artery: Demonstrated by Cardiac Magnetic Resonance Imaging , 2011, Korean circulation journal.

[12]  C. Di Mario,et al.  In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  S. Petersen,et al.  With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. , 2011, Journal of the American College of Cardiology.

[14]  W. Wijns,et al.  Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. , 2010, JACC. Cardiovascular interventions.

[15]  Y. Hayashi,et al.  In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). , 2010, JACC. Cardiovascular interventions.

[16]  Bernard Chevalier,et al.  European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  Patrick W Serruys,et al.  Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. , 2005, European heart journal.

[18]  Gary S. Mintz,et al.  Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II , 2005, Circulation.

[19]  Deepak L. Bhatt,et al.  Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. , 2005, Circulation.

[20]  S. Petersen,et al.  Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging , 2005, Circulation.

[21]  W. Weintraub,et al.  Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. , 2003, American heart journal.

[22]  B. Nallamothu,et al.  Prognostic implication of troponin I elevation after percutaneous coronary intervention. , 2003, The American journal of cardiology.

[23]  David L. Brown,et al.  In‐hospital outcomes of contemporary percutaneous coronary interventions in the very elderly , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  E. Topol,et al.  Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy , 2002, Circulation.

[25]  E. Topol,et al.  Frequency and long-term impact of myonecrosis after coronary stenting. , 2002, European heart journal.

[26]  G. Stone,et al.  Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention , 2001 .

[27]  G. Stone,et al.  Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients , 2001, Circulation.

[28]  R. Kim,et al.  Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.

[29]  E. Topol,et al.  Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.

[30]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[31]  David P Miller,et al.  Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention , 1997 .

[32]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[33]  A. Huqi,et al.  Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. , 2014, Journal of the American College of Cardiology.

[34]  Antonio Colombo,et al.  Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. , 2005, Circulation.

[35]  M. Roea,et al.  Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes , 2004 .